BioSpace News Archive

Healthmap Solutions, a rapidly growing national Population Health Management (PHM) company with a flagship Kidney Health Management (KHM) program, is urging Medicare Advantage (MA) plans to prepare now for the 21st Century CURES Act and a key provision which allows previously ineligible End-Stage Renal Disease (ESRD) patients to select an MA plan during open enrollment for the 2021 calendar year.

RedShift BioAnalytics, Inc. (RedShiftBio), a provider of innovative analytical solutions for protein characterization used in biotherapeutic drug development, is pleased to announce the appointment of Julien Bradley as Chief Executive Officer.

ViTel Net & LSA partner to improve clinician-patient communication in virtual encounters [29-January-2020] MCLEAN, Va. , Jan. 29, 2020 /PRNewswire/ -- ViTel Net and Language Services Associates (LSA) are excited to announce a new platform integration that enables clinicians to immediately add an interpreter to a telehealth video encounter within the existing clini

Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively “HDF”), the beneficial owners of more than 11.8% of the outstanding shares of Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), today issued the following statement commenting on Enzo’s January 28, 2020 press release announcing the postponement of its 2019 Annual Meeting of Shareholders (the “Annual Meeting”

As the U.S. Centers for Disease Control and Prevention continues to investigate more potential U.S. cases of a mysterious coronavirus, InsureMyTrip reports an uptick in calls from concerned travelers seeking clarification on travel insurance coverage..

Synedgen, a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system, today announced that it has received $2.6 million in private financing to fund the commercialization of Catasyn™ Advanced Technology Wound Hydrogel and SynePure™ Wound Cleanser, two U. S. Food and Drug Administration (FDA) 510(k)-cleared products that form part of Synedgen’s Wound Care portfolio.

Jupiter Medical Center is closely monitoring the coronavirus that originated in Wuhan, China, and has implemented the U.S. Centers for Disease Control and Prevention’s guidelines for the screening, diagnosis, and treatment of patients who exhibit the symptoms of and/or are diagnosed with the coronavirus.

Columbia-led study in mice maps brain circuitry that enables a single pheromone to drive both innate and learned sexual behaviors

Mark Bennett, MD, NAPA’s Chairman of Anesthesiology at Chestnut Hill Hospital, collaborated with vascular surgeon Douglas A. Troutman, DO, on a successful high-risk surgical procedure at the community hospital located in Philadelphia, PA

Medigene AG (Medigene, FSE: MDG1, Prime Standard), a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announces today that it has entered into a research collaboration on novel cancer antigens for highly specific immunotherapies with the Université de Montréal (UdeM) and IRICoR, a pan-Canadian drug discovery research commercialization center.